Research & Writings

Two threads run through this page. The current work is on therapeutics — antisense oligonucleotides for a rare chromosomal microduplication. The earlier work is on machine consciousness and transformer interpretability. Both are kept here.

Therapeutics & Longinus

Antisense, rare disease, CYFIP1, and notes from building a biotech.

May 29, 2026

Why I Pivoted from Machine Consciousness to Therapeutics

I spent years working on consciousness and machine cognition. Most of the writing on this site reflects that. Then my older daughter was diagnosed with a chromosomal microduplication that does not have a treatment. The pivot was not a strategic decision.

May 25, 2026

ASO Design as Software Engineering

Antisense oligonucleotides are the closest thing rare disease has to a programmable therapy. The mental model that helped me move fastest into the field is treating ASO development as a software stack — with the same kinds of trade-offs, the same kinds of debugging, and the same kinds of failure modes.

May 20, 2026

CYFIP1 and the Open Niche in 15q11.2

The 15q region gets most of its attention from UBE3A (Angelman, Dup15q) and SHANK3 (Phelan-McDermid). The proximal BP1–BP2 interval, and CYFIP1 inside it, has been left mostly untouched. That gap is not because the biology is uninteresting.

Machine Consciousness

Earlier work on integrated information, transformers, and the question of phenomenal experience in artificial systems.

© 2026 Marcio Diaz · Machine Consciousness Research · Twitter